2023-11-22 21:10:53
bioLytical, in partnership with the NGO Coalition Plus, donated more than 8,000 rapid screening tests to 25 partner countries and organizationsbioLytical is a Canadian company that develops and manufactures all of its screening tests locally for global distributionThe INSTI platform bioLytical’s rapid screening test® is designed to detect a wide range of infectious diseases quickly and accurately. bioLytical’s quality system is PAUMM: ISO 13485 certifiedCoalition PLUS, a global NGO, is an international union of community associations that are used to combat HIV/AIDS and hepatitis
RICHMOND, British Columbia, Nov. 22, 2023 (GLOBE NEWSWIRE) — bioLytical Laboratories Inc. (“bioLytical”), a global leader in rapid in vitro medical diagnostics and its partner Coalition PLUS, a global NGO, announced that together , they have donated and distributed more than 8,000 screening tests in 25 countries to help improve access to screening tests around the world.
International Screening Week, which this year will take place from November 22 to 28, helps raise awareness of the importance of access to screening tests for individual and public health. Testing is one of the essential tools to help connect people to care and reduce the spread of infection, increasing access to testing is essential in the fight to end serious health problems such as HIV and hepatitis.
The pandemic has demonstrated the importance of equitable access to rapid and accurate diagnostic tests to stop the spread of infectious diseases. Rapid and effective screening tests not only save lives, but also help minimize the societal and economic impact of epidemic outbreaks.
As part of our commitment and in support of International Testing Week, bioLytical and the PLUS Coalition are proud to play a global role in improving access to screening tests, reaffirming our commitment to ending some of the world’s most serious health challenges.
Robert Mackie, Managing Director of bioLytical, highlights the importance of International Testing Week and says: “International Testing Week serves as a global reminder of the critical role that rapid screening tests play in protecting public health. Now is the time to raise awareness of the need for early detection, which ultimately contributes to the overall health of communities around the world. We are proud to support this cause through donations of screening tests and to be part of the solution. »
By donating these screening tests, bioLytical and Coalition PLUS aim to address disparities in healthcare access and testing capacity around the world. Improving equitable access to testing helps health care providers have the tools they need to identify infections and quickly provide care and treatment.
Dr Bintou Dembele, Vice President of Coalition PLUS, said: “Community testing for HIV and sexually transmitted infections helps find undiagnosed people often in hard-to-reach populations. International Testing Week aims to highlight awareness interventions that are critical to closing the remaining gaps in the fight against the HIV epidemic. »
bioLytical Laboratories Inc. is an industry leader in the manufacturing of rapid in vitro diagnostic tests focused on infectious diseases with a global mission to ensure that every person has access to accurate and reliable screening tests to know their state of health, more quickly.
Coalition PLUS, created in 2008, is an international union of community associations in the fight against HIV/AIDS and viral hepatitis, operating in 52 countries and alongside around a hundred civil society organizations. These associations promote innovative methods adapted to people facing the greatest discrimination in access to health care.
In addition to its commitment to International Screening Week, bioLytical continues to innovate and develop cutting-edge diagnostic solutions to meet the evolving needs of the healthcare industry. bioLytical remains committed to promoting a healthier, safer and more connected world through rapid diagnostics innovation. By distributing these tests to underserved areas, we hope to facilitate early detection, helping healthcare providers and governments better manage and mitigate the impact of these diseases.
bioLytical Laboratories Inc. is a privately held Canadian company focused on the research, development and commercialization of rapid in vitro medical diagnostics using its patented INSTI® technology platform and lateral flow line, iStatis. bioLytical has won several local and industry awards, including Exporter of the Year in British Columbia in 2019. We were named Growth Stage Medical Technology Company of the Year by Lifesciences in British Columbia and have been on British Columbia’s list of Fastest Growing Companies for seven years, as well as the Globe and Mail’s list of Fastest Growing Companies in 2020. In 2020, bioLytical moved to a much larger, state-of-the-art facility in Richmond, British Columbia, to accommodate the extraordinary growth of our team. Delivering accurate results in one minute or less, the INSTI® line includes the INSTI® HIV-1/HIV-2 Antibody Test, INSTI® Multiplex HIV Syphilis Ab Test, INSTI® HIV Self Test, INSTI® Covid-19 Antibody Test and the INSTI® HCV Antibody Test. bioLytical markets its products in Europe, North America, South America, and Africa and Asia. In 2022, bioLytical launched iStatis, its new lateral flow testing platform to create additional access to screening tests worldwide.
By providing accurate results in real time, INSTI® and iStatis generate meaningful results for healthcare professionals, patients and public health organizations around the world and are key partners in addressing some of the world’s most serious health challenges. health. Please visit www.istatis.com, www.insti.com and www.biolytical.com for more information.
1700693231
#bioLytical #Laboratories #donates #testing